Unclassifiable renal carcinoma with medullary phenotype and SMARCB1 deficiency: case report
BackgroundRenal medullary carcinoma (RMC) is an aggressive tumor representing less than 0.5% of renal cell carcinomas (RCC), and it is considered rare. When it occurs, patients typically have sickle cell trait, sickle cell disease, or an associated hemoglobinopathy, which is a necessary characterist...
Saved in:
| Main Authors: | Samya H. Mehanna, Thiago Gabriel Ronkoski, Cassiano Machado, Lucas S. Wolff, Alexandre C. Cavalli, Thiago Hota, Fernando C. Koleski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Urology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fruro.2025.1582675/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MEDULLARY THYROID CARCINOMA
by: V. S. Medvedev, et al.
Published: (2015-04-01) -
SMARCB1-deficient poorly differentiated testicular carcinoma: a case report
by: Zhiying Wang, et al.
Published: (2025-03-01) -
Overview of management and therapeutic advances in medullary thyroid cancer
by: Mark A Jara, et al.
Published: (2025-03-01) -
A Case of Medullary Carcinoma of the Jejunum Combined with the Intestinal Lymphangiectasia Accompanied by the Malabsorption Syndrome
by: O. A. Lobanova, et al.
Published: (2023-11-01) -
SPORADIC MEDULLARY THYROID CANCER. СASE REPORT
by: L. A. Ivanova, et al.
Published: (2015-04-01)